Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 2
1986 3
1987 2
1988 2
1989 2
1990 1
1991 2
1993 2
1994 1
1995 3
1996 2
1997 1
2000 2
2001 2
2002 4
2003 2
2004 3
2005 4
2006 2
2007 5
2008 4
2009 3
2010 6
2011 3
2012 3
2013 2
2014 6
2015 2
2016 2
2017 1
2018 1
2020 1
2021 3
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

79 results

Results by year

Filters applied: . Clear all
Page 1
Superantigen engineering.
Abrahmsén L. Abrahmsén L. Curr Opin Struct Biol. 1995 Aug;5(4):464-70. doi: 10.1016/0959-440x(95)80030-1. Curr Opin Struct Biol. 1995. PMID: 8528762 Review.
Restoration of conformation of mutant p53.
Green JA, Von Euler M, Abrahmsen LB. Green JA, et al. Among authors: abrahmsen lb. Ann Oncol. 2018 May 1;29(5):1325-1328. doi: 10.1093/annonc/mdy057. Ann Oncol. 2018. PMID: 29462239 Free article. No abstract available.
Early implementation of QbD in biopharmaceutical development: a practical example.
Zurdo J, Arnell A, Obrezanova O, Smith N, Gómez de la Cuesta R, Gallagher TR, Michael R, Stallwood Y, Ekblad C, Abrahmsén L, Höidén-Guthenberg I. Zurdo J, et al. Among authors: abrahmsen l. Biomed Res Int. 2015;2015:605427. doi: 10.1155/2015/605427. Epub 2015 May 17. Biomed Res Int. 2015. PMID: 26075248 Free PMC article. Review.
A thiol-bound drug reservoir enhances APR-246-induced mutant p53 tumor cell death.
Ceder S, Eriksson SE, Cheteh EH, Dawar S, Corrales Benitez M, Bykov VJN, Fujihara KM, Grandin M, Li X, Ramm S, Behrenbruch C, Simpson KJ, Hollande F, Abrahmsen L, Clemons NJ, Wiman KG. Ceder S, et al. Among authors: abrahmsen l. EMBO Mol Med. 2021 Feb 5;13(2):e10852. doi: 10.15252/emmm.201910852. Epub 2020 Dec 14. EMBO Mol Med. 2021. PMID: 33314700 Free PMC article.
Targeting MDM4 as a Novel Therapeutic Approach in Prostate Cancer Independent of p53 Status.
Mejía-Hernández JO, Raghu D, Caramia F, Clemons N, Fujihara K, Riseborough T, Teunisse A, Jochemsen AG, Abrahmsén L, Blandino G, Russo A, Gamell C, Fox SB, Mitchell C, Takano EA, Byrne D, Miranda PJ, Saleh R, Thorne H, Sandhu S, Williams SG, Keam SP, Haupt Y, Haupt S. Mejía-Hernández JO, et al. Among authors: abrahmsen l. Cancers (Basel). 2022 Aug 16;14(16):3947. doi: 10.3390/cancers14163947. Cancers (Basel). 2022. PMID: 36010941 Free PMC article.
Targeting of superantigens.
Kalland T, Dohlsten M, Abrahmsén L, Hedlund G, Björk P, Lando PA, Sundstedt A, Akerblom E, Lind P. Kalland T, et al. Among authors: abrahmsen l. Cell Biophys. 1993 Jan-Jun;22(1-3):147-64. doi: 10.1007/BF03033872. Cell Biophys. 1993. PMID: 7889537 Review.
79 results